Patent Issued for Smallpox vaccine for cancer treatment (USPTO 12036278).

A patent has been issued for a smallpox vaccine that can be used to treat solid tumors and hematologic malignancies. The vaccine can be administered alone or in combination with stem cells or adipose-derived stromal vascular fraction (SVF). The patent claims cover various compositions and methods of administration. The inventors highlight the need for effective cancer treatments, as cancer is a leading cause of death in the United States. [Extracted from the article]